Fertility Treatment Poses No Cardiovascular Risk
Fertility Treatment Poses No Cardiovascular Risk
March 20, 2016
The Jerusalem Post — Undergoing fertility treatments does not raise women’s long-term risk of cardiovascular disease, according to a new study by BGU and Soroka University Medical Center.
The research, led by Prof. Eyal Sheiner, head of obstetrics and gynecology at Soroka, and Prof. Ilana Shoham-Vardi, of BGU’s Faculty of Health Sciences, shows conclusively that in vitro fertilization (IVF) treatments do not endanger women’s hearts and blood vessels.
The study followed the cases of 100,000 women who gave birth at Soroka between 1988 and 2013 for 10 years, focusing on 4,000 who underwent IVF or received drugs that stimulated egg production.
No significant statistical increase in cardiovascular disease was found in women who underwent these treatments as compared to those who did not.
“Now these women can relax at least and not worry about any cardiovascular implications of their treatment,” says Prof. Sheiner.
The results of the study were recently presented at an important obstetrics/gynecological conference in Atlanta.